Despite losing a day, this has been the busiest week of the year for IPOs with 8 IPOs raising $8.9 billion led by Zoom Video (ZM), which popped 72% on its first day of trading after raising $751 million in an IPO that priced above its...read more
Hookipa Pharma, a Phase 2 biotech developing T cell immunotherapies for cancer and infectious diseases, raised $84 million by offering 6 million shares at $14, the low end of the range of $14 to $16. It had previously filed to offer 6.7 million shares at the...read more
A whopping eight IPOs plan to raise $2.5 billion ahead of the Easter holiday weekend, the busiest week of the 2019 IPO market. Year-to-date, 26 IPOs have raised $6.6 billion. While April won't have much pricing activity after this week, May already looks busy,...read more
Hookipa Pharma, a Phase 2 biotech developing T cell immunotherapies for various cancers, announced terms for its IPO on Monday. The New York, NY-based company plans to raise $100 million by offering 6.7 million shares at a price range of $14 to $16....read more
US IPO Weekly Recap: All IPOs up or flat in an 8-IPO week led by Pinterest and Zoom
Despite losing a day, this has been the busiest week of the year for IPOs with 8 IPOs raising $8.9 billion led by Zoom Video (ZM), which popped 72% on its first day of trading after raising $751 million in an IPO that priced above its...read more
Immuno-oncology biotech Hookipa Pharma prices downsized IPO at $14 low end
Hookipa Pharma, a Phase 2 biotech developing T cell immunotherapies for cancer and infectious diseases, raised $84 million by offering 6 million shares at $14, the low end of the range of $14 to $16. It had previously filed to offer 6.7 million shares at the...read more
US IPO Week Ahead: Pinterest and Zoom headline year's busiest week with 8 IPOs
A whopping eight IPOs plan to raise $2.5 billion ahead of the Easter holiday weekend, the busiest week of the 2019 IPO market. Year-to-date, 26 IPOs have raised $6.6 billion. While April won't have much pricing activity after this week, May already looks busy,...read more
Immuno-oncology biotech Hookipa Pharma sets terms for $100 million IPO
Hookipa Pharma, a Phase 2 biotech developing T cell immunotherapies for various cancers, announced terms for its IPO on Monday. The New York, NY-based company plans to raise $100 million by offering 6.7 million shares at a price range of $14 to $16....read more